Why the study?
Does elevated myocardial extracellular potassium concentration enhance procainamide-induced rate-dependent conduction slowing in the intact canine heart?
Does elevated myocardial extracellular potassium concentration enhance procainamide-induced rate-dependent conduction slowing in the intact canine heart?
Elevated extracellular potassium enhances the rate-dependent conduction slowing induced by procainamide in vivo, highlighting a mechanism for altered drug efficacy or proarrhythmia in depolarized tissue.
Answers are grounded in this paper and cite their sources.
May increase procainamide proarrhythmic risk in hyperkalemia; leaves open translation from canine conduction data to patients.
Procainamide, a type 1A antiarrhythmic drug, blocks sodium channels and reduces the maximum rate of rise of the cardiac action potential (Vmax) in a rate-dependent fashion. In vitro, the magnitude of this rate-dependent reduction in Vmax is greater in tissue that is partially depolarized at rest than in tissue with a normal resting potential. Reductions in Vmax produced by drugs that block sodium channels are also directly related to the reductions in longitudinal conduction velocity of action potential propagation in papillary muscle preparations. We therefore sought to determine whether the rate-dependent conduction slowing induced by procainamide in the intact canine heart is enhanced in myocardial tissue abnormally depolarized by an elevated myocardial extracellular potassium concentration, [K+]o. QRS duration and epicardial activation times were measured as indexes of myocardial conduction. QRS duration and epicardial activation times were measured at control (4.0 mM) and at intermediate (6.5 mM) and high (9.2 mM) myocardial [K+]o in the presence or absence of a clinically relevant procainamide concentration (12.2 +/- 2.6 g/ml) at the longest obtainable interstimulus interval of 440 msec and at 330, 280, and 250 msec. Intermediate and high myocardial [K+]o alone induced rate-dependent conduction slowing as the frequency of stimulation increased (cycle length 440 msec to 330, 280, and 250 msec). In the presence of procainamide, rate-dependent conduction slowing was observed at all levels of myocardial [K+]o, and the amount of rate-dependent change in conduction time increased as the myocardial [K+]o was increased.(ABSTRACT TRUNCATED AT 250 WORDS)
No takes yet. Share an insight, caveat, or question.
Cascio et al. (1987) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: